Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chiaroscuro hematopoietic stem cell

P Quesenberry1, M Habibian, M Dooner

  • 1Cancer Center, University of Massachusetts Medical Center, Worcester 01605, USA.

Transactions of the American Clinical and Climatological Association
|May 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fetal treatment of sacrococcygeal teratoma: state of the art.

Frontiers in pediatrics·2025
Same author

Localized myxedema histologically mimicking spindle cell lipoma.

Dermatology online journal·2022
Same author

Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification.

Gynecologic oncology·2022
Same author

Relationship between atrial fibrillatory rate based on analysis of a modified base-apex surface electrocardiogram analysis and the results of transvenous electrical cardioversion in horses with spontaneous atrial fibrillation.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2021
Same author

Clustering of Four-Component Unitary Fermions.

Physical review letters·2020
Same author

Thoracic ultrasound accuracy for the investigation of initial neonatal respiratory distress.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2019
Same journal

THE GORDON WILSON MEMORIAL LECTURE.

Transactions of the American Clinical and Climatological Association·2025
Same journal

HEALTHY AGING: THE PROMISE, AND PERILS, OF GEROSCIENCE.

Transactions of the American Clinical and Climatological Association·2025
Same journal

TESTOSTERONE AND INSULIN RESISTANCE IN MEN: EVIDENCE FOR A COMPLEX BI-DIRECTIONAL RELATIONSHIP.

Transactions of the American Clinical and Climatological Association·2025
Same journal

REVISITING GLUCAGON ACTION IN DIABETES: IS IT ALL BAD?

Transactions of the American Clinical and Climatological Association·2025
Same journal

DECEASED MEMBERS 1884 THROUGH 2024.

Transactions of the American Clinical and Climatological Association·2025
Same journal

OFFICERS AND COUNCIL FALL 2025.

Transactions of the American Clinical and Climatological Association·2025
See all related articles

This study suggests clinical strategies for gene therapy and stem cell expansion, aiming for improved hematopoietic stem cell engraftment. These methods could reduce toxicity in treating blood disorders like sickle cell anemia and in cancer immunotherapies.

Area of Science:

  • Hematology
  • Gene Therapy
  • Immunotherapy

Background:

  • Hematopoietic stem cell (HSC) transplantation is crucial for treating various hematologic diseases and cancers.
  • Current gene therapy and stem cell expansion methods face challenges in optimizing engraftment and minimizing toxicity.
  • Allochimic strategies and cellular immune therapies show promise but require refined engraftment protocols.

Purpose of the Study:

  • To propose immediate clinical strategies for enhancing stem cell engraftment.
  • To explore targeted gene therapy approaches for HSCs.
  • To outline applications for reduced-toxicity stem cell engraftment in genetic blood disorders and cancer immunotherapy.

Main Methods:

  • Targeting hematopoietic stem cells for cycling and retroviral vector integration.

Related Experiment Videos

  • Optimizing time intervals for favorable stem cell engraftment.
  • Utilizing allochimeric strategies for reduced-toxicity stem cell transplantation.
  • Applying cellular immune therapies (T-cell and NK-cell) against cancer.

    • Main Results:

    • Proposed strategies facilitate gene therapy vector integration and HSC engraftment.
    • Stem cell expansion approaches can leverage similar engraftment optimization techniques.
    • Allochimic strategies offer potential for minimal-to-no toxicity in sickle cell anemia and thalassemia treatment.
    • Cellular immune therapies may achieve engraftment with reduced toxicity for cancer treatment.

    Conclusions:

    • Clinical strategies can improve hematopoietic stem cell engraftment efficiency and safety.
    • Targeted gene therapy and stem cell expansion hold significant therapeutic potential.
    • Reduced-toxicity engraftment methods are applicable to genetic blood disorders and cancer immunotherapies.